Provided by Tiger Trade Technology Pte. Ltd.

Accendra Health Inc

0.5052
-0.0526-9.43%
Post-market: 0.51010.0049+0.97%19:30 EDT
Volume:1.81M
Turnover:961.73K
Market Cap:38.85M
PE:-0.13
High:0.5745
Open:0.5600
Low:0.5000
Close:0.5578
52wk High:5.60
52wk Low:0.5000
Shares:76.90M
Float Shares:56.51M
Volume Ratio:1.06
T/O Rate:3.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9457
EPS(LYR):-14.3179
ROE:-198.35%
ROA:0.64%
PB:-0.07
PE(LYR):-0.04

Loading ...

Citigroup Downgrades Accendra Health to Neutral From Buy, Adjusts PT to $1.50 From $4.50

MT Newswires Live
·
Aug 11

Baird Downgrades Accendra Health to Neutral From Outperform, Adjusts PT to $1.50 From $6

MT Newswires Live
·
Aug 11

U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics

Reuters
·
Aug 11

Accendra Health Inc : Baird Cuts to Neutral Rating; Cuts Target Price to $1.5 from $6

THOMSON REUTERS
·
Aug 11

US Closing Bell | Megacaps resist mild pullback as Dow edges 0.1% lower

US Closing Bell
·
Aug 11

Accendra Health Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 10

Accendra Health Shares Slip on Sales-View Cut, Impending CEO Exit

Dow Jones
·
Aug 10

Accendra Health Says Q2 2026 Results Miss Forecast on Weaker Revenue Growth, Slower Collections Recovery

Reuters
·
Aug 10

Accendra Health adopts Section 382 Rights Agreement

TIPRANKS
·
Aug 10

Accendra Health Q2 Profit, Revenue Miss Estimates on Large Payor Exit

Reuters
·
Aug 10

Accendra Health Updates Financial Calendar with Investor Call for Quarterly Results

Reuters
·
Aug 10

Accendra Health Q2 2026 Adjusted Ebitda Drops to $60 Million; GAAP Continuing-Ops Net Loss Widens to $89 Million

Reuters
·
Aug 10

Accendra Health, Inc Q2 Adjusted Ebitda USD 60.1 Million Vs. IBES Estimate USD 61.3 Million

Reuters
·
Aug 10

Accendra Health Chief Executive Edward Pesicka to Retire

MT Newswires Live
·
Aug 10

Accendra Health, Inc Q2 Revenue USD 613.2 Million VS. Ibes Estimate USD 627.3 Million

THOMSON REUTERS
·
Aug 10

Accendra Health, Inc Q2 Adjusted EPS USD -0.19 VS. Ibes Estimate USD -0.09

THOMSON REUTERS
·
Aug 10

Press Release: Accendra Health Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 10

Accendra Health CEO Ed Pesicka Plans Retirement by End-2026, Board Starts Successor Search

Reuters
·
Aug 10

Accendra Health’s Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search

THOMSON REUTERS
·
Aug 10

Accendra Health - Edward A. Pesicka to Retire as President and CEO by End of 2026

THOMSON REUTERS
·
Aug 10